We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
MHRA update on metformin medicines.
The Commission on Human Medicines recommends further precautions for people with weakened immunity and in those aged 60 years or older.
A drug alert has been issued to retailers and healthcare professionals as 4 companies are recalling batches of certain over-the-counter Ranitidine medicines used to treat conditions such as stomach ulcers and heartburn.
Ranitidine – MHRA drug alert issued as Creo Pharma Limited and Tillomed Laboratories recall unexpired stock
The MHRA has issued alerts to healthcare professionals and retailers, as Perrigo Company plc is recalling all unexpired stock of certain batches of Ranitidine medicines used to treat conditions such as heartburn and stomach …
The Medicines and Healthcare products Regulatory Agency (MHRA) is welcoming two directors.…
Teva UK Ltd is recalling unexpired stock of certain batches of 2 types of Ranitidine medicines used to treat conditions such as heartburn and stomach ulcers.
The UK has a unique opportunity to lead the field in Life Sciences, with an exciting and important role for the MHRA.
Successful new format for joint VMD, Veterinary Products Committee open meeting and Pharmaceutical Industry Information Event at the VMD on 25 September 2019
The MHRA has issued an alert to heathcare professionals, as GlaxoSmithKline is recalling all unexpired stock of four types of Zantac, the medicine used to treat conditions such as heartburn and stomach ulcers.
Patients who carry Emerade auto-injector pens for the emergency treatment of severe acute allergic reactions (anaphylaxis) to foods, medicines or insect stings are being reminded of existing advice to carry 2, in-date pens w…
There will be new restrictions on exporting hormone replacement therapy (HRT) products, which currently face supply shortages due to manufacturing issues.
Users of certain Johnson & Johnson Acuvue daily disposable contact lenses are being urged by the MHRA to check their lenses, due to a voluntary product recall of specific lots initiated by the company.
Dr June Raine has become interim Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) today, 23 September 2019.
The MHRA has today announced that 2 Acnecide products will be formally reclassified from pharmacy to general sale list medicines.
Civil Service increases special leave allocation for special constables
The Medicines and Healthcare products Regulatory Agency have released a Strategy for Pharmacopoeial Public Quality Standards for Biological Medicines update.
MHRA and the Bill & Melinda Gates Foundation have begun new research on medicine use which could impact the health of pregnant women around the world.
Women who are current or past users of hormone replacement therapy (HRT) to treat symptoms of the menopause are reminded to be vigilant for signs of breast cancer, even after stopping HRT.
Dr June Raine will become interim Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) from 20 September 2019.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).